HOUSE DOCKET, NO. 2588 FILED ON: 2/18/2021
HOUSE . . . . . . . . . . . . . . . No. 1279
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Bradley H. Jones, Jr.
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Bradley H. Jones, Jr. | 20th Middlesex | 2/8/2021 |
Susan Williams Gifford | 2nd Plymouth | 2/25/2021 |
Angelo L. D'Emilia | 8th Plymouth | 2/26/2021 |
Paul K. Frost | 7th Worcester | 3/11/2021 |
Hannah Kane | 11th Worcester | 3/18/2021 |
Kimberly N. Ferguson | 1st Worcester | 3/22/2021 |
Mathew J. Muratore | 1st Plymouth | 3/25/2021 |
Steven S. Howitt | 4th Bristol | 3/30/2021 |
HOUSE DOCKET, NO. 2588 FILED ON: 2/18/2021
HOUSE . . . . . . . . . . . . . . . No. 1279
By Mr. Jones of North Reading, a petition (accompanied by bill, House, No. 1279) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers. Health Care Financing. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Second General Court
(2021-2022)
_______________
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Notwithstanding any general or special law to the contrary, there shall be a special commission established to assess contracts between the MassHealth program and pharmaceutical benefit managers. The commission shall be tasked with, but not be limited to, evaluating the possible transition of MassHealth from its existing drug purchasing contract model with pharmaceutical benefit managers to a pass-through model.
The commission shall consist of 10 members: the state auditor, or a designee; the secretary of health and human services, or a designee; the director of MassHealth, or a designee; the director of insurance, or a designee; the speaker of the house of representatives, or a designee; the senate president, or a designee; the minority leader of the house of representatives, or a designee; the minority leader of the house, or a designee; one member who shall advocate on behalf of pharmaceutical benefit managers, to be appointed by the governor; and one member who shall advocate on behalf of pharmacies, to be appointed by the governor.
The commission shall submit its report and findings, along with any draft of legislation, to the house and senate committees on ways and means, the joint committee on health care financing, and the clerks of the house of representatives and the senate within 1 year of the passage of this act.